NCT05279300 2025-08-11
A Study of CS5001 in Patients With Advanced Solid Tumors and Lymphomas
CStone Pharmaceuticals
Phase 1 Recruiting
CStone Pharmaceuticals
M.D. Anderson Cancer Center
Southern Europe New Drug Organization
The Cleveland Clinic
Case Comprehensive Cancer Center